VCEL
Vericel Corp
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
about vericel founded in 1989, vericel (formerly aastrom biosciences), is dedicated to the development of patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. the company markets two cell therapy products in the united states, carticel® (autologous cultured chondrocytes), an autologous chondrocyte implant for the treatment of cartilage defects in the knee and epicel® (cultured epidermal autografts), a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. vericel is also developing maci, a third-generation autologous chondrocyte implant for the treatment of cartilage defects in the knee, and ixmyelocel-t, a patient specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy (dcm). to fulfill vericel’s mission of helping people with severe diseases and conditions rea
Market Cap: 2.18 Billion
Primary Exchange: NASDAQ
Website: https://vcel.com/
Shares Outstanding: 48.3 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.351715567093985
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Ethical Flags
Longest drawdown: 2098 trading days
From: 2013-01-04 To: 2020-11-27
Lowest Point:
Target Acquired: The NexoBrid Acquisition And Its Implications For Vericel
via: SeekingAlpha at 2019-06-10 04:41:34:000
For a year, Vericel ( VCEL ) teased investors with hints that it would be adding an acquisition to its product line. After doing a large, surprise secondary offering of $75 million in June 2018, Vericel indicated it was actively on the hunt for " commercial products or businesses which would … read more...
Target Acquired: The NexoBrid Acquisition And Its Implications For Vericel
via: SeekingAlpha at 2019-06-10 04:41:34:000
For a year, Vericel ( VCEL ) teased investors with hints that it would be adding an acquisition to its product line. After doing a large, surprise secondary offering of $75 million in June 2018, Vericel indicated it was actively on the hunt for " commercial products or businesses which would … read more...
Target Acquired: The NexoBrid Acquisition And Its Implications For Vericel
via: SeekingAlpha at 2019-06-10 04:41:34:000
For a year, Vericel ( VCEL ) teased investors with hints that it would be adding an acquisition to its product line. After doing a large, surprise secondary offering of $75 million in June 2018, Vericel indicated it was actively on the hunt for " commercial products or businesses which would … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2013-10-16 | 20.0 | 1.0 | 20.0 |